NIBRT's World Leading Contract Research
The National Institute for Bioprocessing Research and Training (NIBRT) is a global centre of excellence for training and research in bioprocessing.
World leading NIBRT principal investigators and scientific advisors, including Dr Jonathan Bones and Professor Pauline Rudd, continue to drive advancements in the field of bioprocessing analytics through pioneering and innovative research.
We are a team of characterisation specialists who provide detailed analysis of biologics in line with ICH Q6B and Q5E requirements. Our highly regarded scientists, renowned for their glycan analysis expertise, are situated in the award winning NIBRT facility with access to a state-of-the-art laboratory equipped with top-of-the-line instrumentation.
Working adjacent to our accomplished team of Principal Investigators carrying out cutting edge, industry aligned research in all areas of biopharmaceutical manufacturing, we are well positioned to support our clients in solving problems at all stages of their product development and production.
With over ten years’ experience we have analysed a variety of proteins and glycoproteins expressed in a range of cell lines and expression systems.
- Monoclonal antibodies
- Fusion proteins
At NIBRT Contract Research we take the time to understand our clients’ requirements. With extensive experience managing complex characterisation projects, our team consistently delivers to the highest standard. We can provide our clients with:
- Bespoke projects, flexible scheduling and quick response times.
- Clear communication and updates throughout the project lifetime.
- Tailored and detailed reports to ensure full clarity of data and results.
- A subject matter expert and dedicated analysts who offer support throughout the project lifetime.
Listen to our Webinar on Glycan Characterisation
Download a list of our services
Connect with Our Scientific Community on LinkedIn
Dr Simon Westbrook
NIBRT Contract Research has enabled Levicept to access a wide range of analytical services delivered through the provision of top specification analytical instrumentation.
In addition to providing protein and glycan analytical services their ability to develop new methods to meet our specific needs enables us to quickly resolve our analytical queries in timely and cost effective manner.
Working with NIBRT Contract Research has enable us to gain a greater understanding of our clinical candidate.
Top-tier patent litigation boutique law firm, London
NIBRT came highly recommended from a contact in New York and we were not disappointed: Patrick Jennings and his team did a fantastic job for us on a very short turnaround.
Within a couple of weeks they had optimised several testing processes for measuring the purity of an antibody for the purposes of litigation and provided helpful results that were strategically important to the case.
No amount of effort was too much and Patrick and Caitriona provided daily updates, slide decks and telephone calls to keep the team apprised as to progress, Patrick even going so far as taking delivery of an HPLC column at his home address on a Saturday so that a valuable day’s testing could be saved.
We would recommend them universally and thoroughly enjoyed the experience of working with them.
Ten out of ten for service, quality and professionalism.
North American Law firm specialising in intellectual property
We came across NIBRT Contract Research through our work with a leading expert in the Biotherapeutic characterisation field.
From first contact, NIBRT Contract Research has been an outstanding facility to work with.
The team at NIBRT Contract Research has been instrumental in pushing the boundaries of our testing needs. They are not only flexible, responsive and a pleasure to work with, they also go several steps further to help us problem solve and develop new ways to test our products and learn more about our systems.
NIBRT Contract Research is a top class analytical facility and we will continue to work with them and recommend them to our colleagues going forward.
We would use no one else.
Biologics Development, Horizon Therapeutics
“The NIBRT team’s extensive support and quality work was integral
in the success of our regulatory submission to the U.S. FDA.”